Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H22N2O |
Molecular Weight | 294.3908 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12N3CCC[C@@]1(CC)CC(=O)N4C5=CC=CC=C5C(CC3)=C24
InChI
InChIKey=WYJAPUKIYAZSEM-MOPGFXCFSA-N
InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3/t18-,19+/m1/s1
Molecular Formula | C19H22N2O |
Molecular Weight | 294.3908 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2263666 | https://www.exercise.com/supplements/vinburnine | http://www.drugfuture.com/chemdata/eburnamonine.html | https://www.ncbi.nlm.nih.gov/pubmed/14306194 | https://ir.nctu.edu.tw/bitstream/11536/25464/1/000233154200020.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/2263666Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/2287808
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2263666 | https://www.exercise.com/supplements/vinburnine | http://www.drugfuture.com/chemdata/eburnamonine.html | https://www.ncbi.nlm.nih.gov/pubmed/14306194 | https://ir.nctu.edu.tw/bitstream/11536/25464/1/000233154200020.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/2263666
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/2287808
Vinburnine is a nutritional product, which is semi-synthesized from vincamine. It is a peripheral vasodilator with cerebral activities that also act as a cerebral metabolic stimulant and appears to be able to relax the smooth muscle cells within the walls of blood vessels. Some evidence also suggests that vinburnine stimulates acetylcholine neurotransmission. Acetylcholine is a very important neurotransmitter responsible for a number of cognitive functions, such as memory and learning.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P08172 Gene ID: 1129.0 Gene Symbol: CHRM2 Target Organism: Homo sapiens (Human) Sources: http://drugcentral.org/drugcard/2824 |
68.9 µM [Kd] | ||
Target ID: P11229 Gene ID: 1128.0 Gene Symbol: CHRM1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/9224827 |
7.54 µM [Kd] | ||
Target ID: P20309 Gene ID: 1131.0 Gene Symbol: CHRM3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/9224827 |
6.67 µM [Kd] | ||
Target ID: P08173 Gene ID: 1132.0 Gene Symbol: CHRM4 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/9224827 |
23.7 µM [Kd] | ||
Target ID: acetylcholine neurotransmission Sources: https://www.ncbi.nlm.nih.gov/pubmed/2263666 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | CERVOXAN Approved UseCerebrovascular diseases |
|||
Sample Use Guides
In Vivo Use Guide
Sources: https://neurotropix.us/buy/vinburnine.html
The recommended dosage is 60 mg taken twice a day.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26666648
Curator's Comment: Different concentrations of the drugs: vincamine, vinpocetine and eburnamonine (VINBURNINE) (4, 20 and 100 µM) induced minimal stimulation of the ATPase activity of the Bcrp and Pgp membrane transporters. The relative metabolic stability of eburnamonine compared to the other alkaloids suggests the use of eburnamonine or its derivatives as lead compounds for the development of antitumor and nootropic agents that need to cross the BBB and produce their pharmacological effects in the CNS.
Different concentrations of the three drugs, vincamine, vinpocetine, and eburnamonine, (4, 20 and 100 uM) induced minimal stimulation of the ATPase activity of the Bcrp and Pgp membrane transporters.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:43:03 GMT 2023
by
admin
on
Sat Dec 16 17:43:03 GMT 2023
|
Record UNII |
G54D0HMY25
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C932
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
||
|
WHO-VATC |
QC04AX17
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
||
|
NCI_THESAURUS |
C29707
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
||
|
WHO-ATC |
C04AX17
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C152880
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
322920
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
G54D0HMY25
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
DB13793
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
CHEMBL1892145
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
57954
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | RxNorm | ||
|
4880-88-0
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
C016422
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
4976
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
SUB00053MIG
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
2824
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
225-490-5
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
71203
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
m4804
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000079106
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
DTXSID6045119
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY | |||
|
VINBURNINE
Created by
admin on Sat Dec 16 17:43:03 GMT 2023 , Edited by admin on Sat Dec 16 17:43:03 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |